Literature DB >> 23839878

Total intravenous anesthesia combined with epidural eptazocine.

S Aida1, T Tomiyama, K Shimoji.   

Abstract

To reduce the doses of intravenous anesthetics (ketamine, diazepam, droperidol, and vecuronium) used in total intravenous anesthesia (TIVA), epidural administration of a ϰ-stimulating opioid, eptazocine, was combined with TIVA in 115 patients. Surgical procedures were uneventful under TIVA plus epidural eptazocine; significant depression of EEG and somatosensory-evoked potentials during anesthesia were observed without delay in recovery. The circulatory response and blood glucose level during and after anesthesia and surgery were stable, and there was no postanesthetic respiratory depression. On the other hand, in 46 patients given TIVA only, hypertension, tachycardia, and elevated blood glucose during and after anesthesia were observed: in 25 (54.3%) patients, a vasodepressor was required, and in 18 (39.1%) patients, nitrous oxide was needed. Therefore, epidural eptazocine may make it possible to use lower doses of anesthesia in TIVA, thus reducing the adverse effects associated with TIVA such as hypertension during surgery, intraoperative awareness, postanesthetic respiratory depression, delayed recovery from anesthesia, and neurological signs after anesthesia. This may be due to the ϰ-stimulating action of epidural eptazocine on the spinal cord and its σ-blocking action, as well as its lack of μ-action on the brain.

Entities:  

Year:  1995        PMID: 23839878     DOI: 10.1007/BF02479943

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  30 in total

1.  Rapid-sequence orotracheal intubation: a comparison of three techniques.

Authors:  S M Silverman; R D Culling; R E Middaugh
Journal:  Anesthesiology       Date:  1990-08       Impact factor: 7.892

2.  Ketamine, diazepam, and Innovar. A computerized comparative study.

Authors:  G E Thompson; D C Moore
Journal:  Anesth Analg       Date:  1971 May-Jun       Impact factor: 5.108

3.  Effects of two new dissociative anesthetic agents, ketamine and CL-1848C, on the respiratory response to carbon dioxide.

Authors:  R W Kelly; R D Wilson; D L Traber; L L Priano
Journal:  Anesth Analg       Date:  1971 Mar-Apr       Impact factor: 5.108

4.  Studies of the mechanism of cardiovascular responses to CI-581.

Authors:  E G Dowdy; K Kaya
Journal:  Anesthesiology       Date:  1968 Sep-Oct       Impact factor: 7.892

5.  Mid-latency auditory evoked potentials during ketamine anaesthesia in humans.

Authors:  D Schwender; S Klasing; C Madler; E Pöppel; K Peter
Journal:  Br J Anaesth       Date:  1993-11       Impact factor: 9.166

6.  The effect of ketamine on transmembrane potentials of Purkinjé fibres of the pig heart.

Authors:  J T Hamilton; J S Bryson
Journal:  Br J Anaesth       Date:  1974-09       Impact factor: 9.166

7.  The effect of diazepam on airway resistance in asthmatics.

Authors:  J Heinonen; A Muittari
Journal:  Anaesthesia       Date:  1972-01       Impact factor: 6.955

8.  Ketamine hydrochloride in severe bronchospasm.

Authors:  M M Fischer
Journal:  Anaesthesia       Date:  1977-09       Impact factor: 6.955

9.  Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes.

Authors:  R J McDonough; J J Madden; A Falek; D A Shafer; M Pline; D Gordon; P Bokos; J C Kuehnle; J Mendelson
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

10.  Mechanisms of the relaxant action of ketamine on isolated porcine trachealis muscle.

Authors:  L E Wilson; D J Hatch; K Rehder
Journal:  Br J Anaesth       Date:  1993-10       Impact factor: 9.166

View more
  1 in total

1.  Comparison of circulatory and respiratory responses between supplementary epidural buprenorphine and eptazocine administration during and immediately after total intravenous anesthesia.

Authors:  S Aida; H Baba; K Shimoji
Journal:  J Anesth       Date:  1997-06       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.